Berry Genomics

Berry Genomics is a leading company in clinical genomics and life science in China. Founded in 2010, the company is dedicated to research, development, and commercialization of genetic test technologies in clinical applications, focusing on Biotechnology, Health Care, and Life Sciences. Berry Genomics aims to assist accurate diagnosis of diseases throughout the full human life circle, and to improve human health. The company’s commitment to advancing genetic testing technologies positions it at the forefront of the biotechnology industry in China. Although specific details about the last investment and investors are not currently available, Berry Genomics' presence and influence in the clinical genomics and life science sectors in China make it a company worth considering for potential investment opportunities.